{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7747,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "comparison_table",
      "function": "analyze_data",
      "notes": "Forest plot showing hazard ratios with 95% confidence intervals for multiple clinical subgroups.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/29",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-29",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 26,
          "beatId": "617689da-c69b-43c7-8222-b2a08def2699",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents the positive results of the NIAGARA trial.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "comparison_table",
      "function": "analyze_data",
      "notes": "The table compares safety data across various categories of adverse events, including grade 3/4, serious AEs, and treatment-related outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/30",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-30",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 26,
          "beatId": "617689da-c69b-43c7-8222-b2a08def2699",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents the positive results of the NIAGARA trial.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "comparison_table",
      "function": "analyze_data",
      "notes": "The chart uses a diverging bar structure to compare two treatment arms side-by-side.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/31",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-31",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/32",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-32",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "Includes corporate branding and a biological illustration of an antibody-drug conjugate or similar protein structure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/33",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-33",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "problem_statement",
      "function": "diagnose_problem",
      "notes": "The slide uses a market segmentation approach to map clinical trials (NIAGARA, POTOMAC, VOLGA, NILE) to patient populations (NMIBC, MIBC, 1L mUC).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/34",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-34",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide uses a three-row structure to categorize reasons for confidence: clinical evidence, safety/experience, and implementation/stakeholder alignment.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/35",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-35",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "team_bio",
      "function": "introduce_nominees",
      "notes": "Slide lists 6 internal leaders and 1 external expert.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/36",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "The slide features a 3D rendering of an antibody molecule.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/37",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The chart is a stacked area chart showing market growth by target segment (HER2, TROP2, Nectin4, etc.).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/38",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "kpi_overview",
      "function": "present_solution",
      "notes": "The slide uses a horizontal bar chart to represent clinical development stages for six different ADC assets.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/39",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "The slide compares plasma concentration over time for two different ADCs, showing the stability of the ADC vs the mAb and the low levels of free payload.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/40",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-40",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "Waterfall plot shows best change in target lesion size; includes CA-125 response markers.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/41",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "key_takeaways",
      "function": "analyze_data",
      "notes": "Waterfall plot shows RECIST v1.1 response criteria. Includes legend for dose levels and callout boxes for clinical outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/42",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "section_divider",
      "function": "transition",
      "notes": "The slide features a stylized 3D rendering of a bispecific antibody molecule.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/43",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "other",
      "function": "present_solution",
      "notes": "The slide highlights the structural design (knob-into-hole) and clinical development pipeline for two specific IO assets.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/44",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "WCLC conference presentation slide. Includes waterfall plot and summary table of ORR and treatment continuation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/45",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "key_takeaways",
      "function": "analyze_data",
      "notes": "Spider plot (swimmer plot variant) showing individual patient response trajectories.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/46",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "Waterfall plot shows tumor shrinkage; includes key clinical metrics (ORR, mPFS) and safety/future trial status.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/47",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-47",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "closing_ask",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/48",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-48",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The chart uses a bridge/waterfall structure to show revenue growth drivers.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/49",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-49",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 50,
      "slideType": "timeline",
      "function": "plan_implementation",
      "notes": "The slide uses a grid-based layout to organize events by year, with checkmarks indicating completed or high-priority milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/50",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-50",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "team_bio",
      "function": "introduce_nominees",
      "notes": "The slide lists six key executives with their titles and headshots.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/51",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-51",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 52,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/52",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-52",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 53,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide uses a grid layout to categorize clinical trials by disease stage and patient population, highlighting established standards of care (SoC) with hatched patterns.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/53",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-53",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 54,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide uses a matrix structure to categorize clinical trials (e.g., DESTINY-Breast, TROPION-Breast, CAPItello) by patient population and treatment line.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/54",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-54",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 55,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/55",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-55",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2ede-72aa-ade1-9df6586a5c43",
      "docSlug": "07da8690ded5d079d6760889d2f598d8",
      "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides",
      "authorId": "benevolentai",
      "authorName": "BenevolentAI",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/-zuNkRTvEnoTMmg7N8-5pgCOc5O7k05HyicoVlSSgbE/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wN2RhODY5MGRlZDVkMDc5ZDY3NjA4ODlkMmY1OThkOC9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/1",
      "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43",
      "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/0i1CF1g21WpK6SFmkTjkx3bLv5YiJ5pWrMpyGK6OU0s/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wN2RhODY5MGRlZDVkMDc5ZDY3NjA4ODlkMmY1OThkOC9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/Tqov8nw0BV55Ft5lZ1ixXghU1PwtXDRUv4TBZn9Otfc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wN2RhODY5MGRlZDVkMDc5ZDY3NjA4ODlkMmY1OThkOC9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/aoA6joonwq92FLYuI5NdXkInTiwLz405k6Gptlb_H48/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wN2RhODY5MGRlZDVkMDc5ZDY3NjA4ODlkMmY1OThkOC9wMDAxLnBuZw"
    },
    {
      "docId": "019de077-2ede-72aa-ade1-9df6586a5c43",
      "docSlug": "07da8690ded5d079d6760889d2f598d8",
      "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides",
      "authorId": "benevolentai",
      "authorName": "BenevolentAI",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/2",
      "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43",
      "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2ede-72aa-ade1-9df6586a5c43",
      "docSlug": "07da8690ded5d079d6760889d2f598d8",
      "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides",
      "authorId": "benevolentai",
      "authorName": "BenevolentAI",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "timeline",
      "function": "show_traction",
      "notes": "The slide uses a non-linear, interconnected circular node design to represent a timeline.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/3",
      "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43",
      "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}